At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Black tea extract +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Double Blind Placebo Controlled Crossover Study to Assess the Effect of Black Tea on Flow-Mediated Dilation in Healthy, Non-tea Drinking Males
In Brief
A clinical study evaluating Black tea extract, Positive control, and 1 other intervention for Vascular Function. Completed, enrolled 30 participants across 1 site.
Detailed Summary
Epidemiological studies indicate that regular consumption of three cups of black tea per day reduces the risk of stroke or myocardial infarction. In a number of previous nutrition intervention studies tea has been shown to improve vascular function as assessed by Flow Mediated Dilation (FMD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVascular Function
CountriesItaly
CollaboratorsSprim Advanced Life Sciences
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartSep 2013
First PostedSep 2013
Primary CompletionNov 2013
Study CompletionDec 2013
TodayJul 2026
First PostedSep 19, 2013
Enrollment StartSep 1, 2013
Primary CompletionNov 1, 2013
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 12.8 years ago
Interventions
Black tea extractother
Black tea extract
Positive controlother
Positive control
Placeboother
Placebo